Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the protocol is to determine the effect of BN83495 on the progression of
endometrial cancer with estrogen receptor in post menopausal women who had previously
received chemotherapy.